A group of African women leaders have come together to form the Africa Breast Cancer Council, with the support of Roche, one of the world’s largest biotech companies.
The Africa Breast Cancer Council is a response to the growing burden of breast cancer on the African continent. Breast cancer is the most commonly diagnosed cancer in women in Africa and causes the most cancer-related deaths. Only one in two women in sub-Saharan Africa are currently expected to survive for five years after receiving a diagnosis.
The Council will leverage its extensive, diverse, and complementary experience to guide and drive policy change in its home countries and across the continent. They will encourage increased collaboration, better data collection, and improved patient outcomes. The Council’s work will seek to foster systemic improvements in healthcare infrastructure, access, and funding, driving sustainable, scalable impact for breast cancer care. The Council will focus initially on African healthcare systems that are open to partnership and innovation, then move to scale this work across the continent.
Dr Miriam Mutebi, Africa Breast Cancer Council member and Breast Cancer Surgical Oncologist at the Aga Khan University Hospital in Nairobi said: “This Council has chosen to launch during Breast Cancer Awareness Month, a recognized annual global movement to drive awareness and improve early detection and thus outcomes. We are using this month to start raising our collective voice, alongside others committed to reducing the unacceptable toll of breast cancer on African women. As the work progresses, we will be highlighting the critical gaps that different countries in Africa need to close, to speed up effective breast cancer diagnosis and treatment and survivorship.”
It can take more than six months for women in Africa to receive a breast cancer diagnosis after noticing symptoms, due in part to healthcare system inefficiencies and limited access to specialized care. This contributes to 60-70% of African women receiving a diagnosis in the late stage, reducing chances of survival and increasing cancer care costs with more expensive therapies and longer hospital stays. This is exacerbated by a lack of awareness of the importance of breast self-checks, along with widespread stigma surrounding breast cancer treatment. In light of this need, the Council will work at a national level to reduce the time to diagnosis from six months to 60 days.
In Kenya, more than 60% of women with breast cancer are diagnosed at a late stage. On an individual level, a lack of knowledge of the symptoms and curability of breast cancer along with the geographic distance to health centres contribute to late detection. At a national level, a lack of integrated health systems, resulting in complex patient pathways and the cost of cancer care, also present barriers to treatment.
Absa Bank Kenya hosts women entrepreneurs for the PanAfrican InspireME Conference
Wendy Cupido, Africa Breast Cancer Council Co-chair and General Manager at Roche South Africa and Sub Region said: “Every woman on this Council has a day job that plays an important role in the fight against breast cancer. Our aim in coming together is to channel our knowledge, expertise, relationships, and energy into a collective voice, and a collective force, to focus on significant areas of concern.”
Dr Magda Robalo, Africa Breast Cancer Council member and President and Co-founder, the Institute for Global Health and Development said: “Most African women with breast cancer are diagnosed too late and, even after a diagnosis, many do not receive the treatment they need. This egregious injustice is utterly preventable. In response, the Africa Breast Cancer Council will work to shape policies and advocate for governments to urgently commit the resources needed.”